Effects of allicin on the proliferation and apoptosis of transplanted hepatocellular carcinoma
Zhi-mian ZHANG,Ning ZHONG,Hai-qing GAO,Shang-zhong ZHANG,Yuan WEI,Hua XIN,Xing MEI,Huai-shui HOU,Xi-yun LIN,Qing SHI
DOI: https://doi.org/10.3760/j:issn:0254-9026.2005.03.017
2005-01-01
Abstract:Objective To evaluate the therapeutic effect of allicin on heapatocellular carcinoma in vivo and to furnish theoretical and methodological basis for the clinical application of allicin in interventional therapy of heaptocellular carcinoma. Methods The transplanted tumor model was established by injecting human hepatocellular carcinoma BEL -7402 cell into subcutaneous tissue of nude mice. The growth curve of these transplanted tumor cells was measured. Thirty nude mice were divided into 6 groups at random: 0.1 ml of normal saline tween solution,1 mg/ml allicin,2 mg/ml allicin,5 mg/ml allicin,1 mg/ml allicin plus 0.2 mg/ml adriamycin directly injected into tumor body respectively by interventional methods, for seven times at an interval of two days. The changes of tumor volume,the tumor inhibition rate, the morphologic alterations under light microscope by HE staining and electron microscope, and the apoptosis rate with TUNEL assay were observed. The expression of apoptosis-associated FasL mRNA before and after above treatments by using of RT-PCR assay was analyzed. Results The growth curve of transplanted BEL-7402 cells was exponential.The inhibition rates were 62.8%,72.8%,94.5%,76.0% and 87.0% respectively in the above groups.The apoptosis indices were (2.2±1.1)%,(17.2±2.8)%,(19.4±2.1)%,(28.3±3.0)%,(22.4±2.5)% and (37.6±3.9)%,respectively.The expression of FasL mRNA was remarkably up-regulated in allicin group and adriamycin group, especially in allicin plus adriamycin group.The increased necrotic cells and typical apoptosis cells in the transplanted tumor tissue under electron microscope were observed in the allicin or (and) adriamycin group. Conclusions Allicin can inhibit the growth of transplanted hepatocellular carcinoma cells effectively in vivo by interventional method, exhibiting a dose-dependent relationship. Allicin may induce apoptosis of transplanted human hepatocellular carcinoma cells in vivo and up-regulate the expression of FasL mRNA.